Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin

Hepatitis E virus (HEV) infection has emerged as a global health issue, but no approved medication is available. The nucleoside analogue 2’-C-methylcytidine (2CMC), a viral polymerase inhibitor, has been shown to inhibit infection with a variety of viruses, including hepatitis C virus (HCV). Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Changbo, Xu, Lei, Yin, Yuebang, Peppelenbosch, Maikel P., Pan, Qiuwei, Wang, Wenshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602043/
https://www.ncbi.nlm.nih.gov/pubmed/28623406
http://dx.doi.org/10.1007/s00705-017-3444-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602043/
https://www.ncbi.nlm.nih.gov/pubmed/28623406
http://dx.doi.org/10.1007/s00705-017-3444-8

Ejemplares similares